Biobanking Leadership Position PrecisionMed as a premier source of longitudinal CSF and annotated human biospecimens with rich clinical data, enabling pharma and biotech biomarker discovery, target validation, and drug development.

Turnkey Clinical Collection Offer end-to-end, compliant sample collection in the United States using IRB-approved protocols and a network of physician sites, making PrecisionMed a preferred partner for clinical trial supply across multiple therapeutic areas.

Acquisition Synergy Leverage the BioIVT acquisition to expand reach by cross-selling PrecisionMed's CSF and biospecimen assets to BioIVT's existing customer base, accelerating market penetration and collaboration opportunities.

Diverse Customer Base Capitalize on a broad customer base that includes major pharma/biotech firms as well as academic and government researchers to upsell data-rich samples, biomarker datasets, and related analytics services for research and diagnostics development.

Data and Tech Value Promote analytics-ready offerings supported by a scalable tech stack (databases, cloud infrastructure) to bundle sample access with data packages and integration-ready datasets for downstream research and decision-making.